436 related articles for article (PubMed ID: 19027780)
1. SCN5A channelopathies--an update on mutations and mechanisms.
Zimmer T; Surber R
Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of SCN5A-related cardiac arrhythmias.
Charpentier F; Bourgé A; Mérot J
Prog Biophys Mol Biol; 2008; 98(2-3):230-7. PubMed ID: 19041666
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel.
Wilde AA; Brugada R
Circ Res; 2011 Apr; 108(7):884-97. PubMed ID: 21454796
[TBL] [Abstract][Full Text] [Related]
4. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.
Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P
Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
6. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
Remme CA; Wilde AA; Bezzina CR
Trends Cardiovasc Med; 2008 Apr; 18(3):78-87. PubMed ID: 18436145
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
Smits JP; Blom MT; Wilde AA; Tan HL
Expert Opin Pharmacother; 2008 Mar; 9(4):537-49. PubMed ID: 18312156
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.
Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW
Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786
[TBL] [Abstract][Full Text] [Related]
9. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
10. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.
Smits JP; Koopmann TT; Wilders R; Veldkamp MW; Opthof T; Bhuiyan ZA; Mannens MM; Balser JR; Tan HL; Bezzina CR; Wilde AA
J Mol Cell Cardiol; 2005 Jun; 38(6):969-81. PubMed ID: 15910881
[TBL] [Abstract][Full Text] [Related]
11. Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy.
Rossenbacker T; Schollen E; Kuipéri C; de Ravel TJ; Devriendt K; Matthijs G; Collen D; Heidbüchel H; Carmeliet P
J Med Genet; 2005 May; 42(5):e29. PubMed ID: 15863661
[TBL] [Abstract][Full Text] [Related]
12. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
13. Cardiac sodium channel Na(v)1.5 and interacting proteins: Physiology and pathophysiology.
Abriel H
J Mol Cell Cardiol; 2010 Jan; 48(1):2-11. PubMed ID: 19744495
[TBL] [Abstract][Full Text] [Related]
14. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
[TBL] [Abstract][Full Text] [Related]
15. Cardiac sodium channel Nav1.5 and its associated proteins.
Abriel H
Arch Mal Coeur Vaiss; 2007 Sep; 100(9):787-93. PubMed ID: 18033008
[TBL] [Abstract][Full Text] [Related]
16. [Inherited cardiac diseases caused by Nav1.5 sodium channel mutations].
Tfelt-Hansen J; Olesen SP; Svendsen JH; Jespersen T
Ugeskr Laeger; 2009 Apr; 171(15):1261-5. PubMed ID: 19416615
[TBL] [Abstract][Full Text] [Related]
17. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
[TBL] [Abstract][Full Text] [Related]
18. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
[TBL] [Abstract][Full Text] [Related]
19. Biology of cardiac sodium channel Nav1.5 expression.
Rook MB; Evers MM; Vos MA; Bierhuizen MF
Cardiovasc Res; 2012 Jan; 93(1):12-23. PubMed ID: 21937582
[TBL] [Abstract][Full Text] [Related]
20. Mutational screening of SCN5A linked disorders in Polish patients and their family members.
Moric-Janiszewska E; Herbert E; Cholewa K; Filipecki A; Trusz-Gluza M; Wilczok T
J Appl Genet; 2004; 45(3):383-90. PubMed ID: 15306732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
